BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26603156)

  • 1. S1P2/G12/13 Signaling Negatively Regulates Macrophage Activation and Indirectly Shapes the Atheroprotective B1-Cell Population.
    Grimm M; Tischner D; Troidl K; Albarrán Juárez J; Sivaraj KK; Ferreirós Bouzas N; Geisslinger G; Binder CJ; Wettschureck N
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):37-48. PubMed ID: 26603156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
    Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.
    Bai L; Li Z; Li Q; Guan H; Zhao S; Liu R; Wang R; Zhang J; Jia Y; Fan J; Wang N; Reddy JK; Shyy JY; Liu E
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1470-1481. PubMed ID: 28642237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
    Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid HMG-CoA (3-Hydroxy-3-Methylglutaryl-Coenzyme A) Reductase Determines Atherosclerosis by Modulating Migration of Macrophages.
    Sakai K; Nagashima S; Wakabayashi T; Tumenbayar B; Hayakawa H; Hayakawa M; Karasawa T; Ohashi K; Yamazaki H; Takei A; Takei S; Yamamuro D; Takahashi M; Yagyu H; Osuga JI; Takahashi M; Tominaga SI; Ishibashi S
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2590-2600. PubMed ID: 30354246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis.
    Wei Y; Zhu M; Corbalán-Campos J; Heyll K; Weber C; Schober A
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):796-803. PubMed ID: 25810298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Role of C3aR (C3a Anaphylatoxin Receptor) Against Atherosclerosis in Atherosclerosis-Prone Mice.
    Wei LL; Ma N; Wu KY; Wang JX; Diao TY; Zhao SJ; Bai L; Liu E; Li ZF; Zhou W; Chen D; Li K
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2070-2083. PubMed ID: 32762445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice.
    Poupel L; Boissonnas A; Hermand P; Dorgham K; Guyon E; Auvynet C; Charles FS; Lesnik P; Deterre P; Combadiere C
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2297-305. PubMed ID: 23887641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thioredoxin-1 promotes anti-inflammatory macrophages of the M2 phenotype and antagonizes atherosclerosis.
    El Hadri K; Mahmood DF; Couchie D; Jguirim-Souissi I; Genze F; Diderot V; Syrovets T; Lunov O; Simmet T; Rouis M
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1445-52. PubMed ID: 22516068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 27 inhibits atherosclerosis via immunoregulation of macrophages in mice.
    Hirase T; Hara H; Miyazaki Y; Ide N; Nishimoto-Hazuku A; Fujimoto H; Saris CJ; Yoshida H; Node K
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H420-9. PubMed ID: 23729211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
    Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
    Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral factors secreted from adipose tissue-derived mesenchymal stem cells ameliorate atherosclerosis in Ldlr-/- mice.
    Takafuji Y; Hori M; Mizuno T; Harada-Shiba M
    Cardiovasc Res; 2019 May; 115(6):1041-1051. PubMed ID: 30388208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
    Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A thioredoxin-mimetic peptide exerts potent anti-inflammatory, antioxidant, and atheroprotective effects in ApoE2.Ki mice fed high fat diet.
    Canesi F; Mateo V; Couchie D; Karabina S; Nègre-Salvayre A; Rouis M; El Hadri K
    Cardiovasc Res; 2019 Feb; 115(2):292-301. PubMed ID: 30010817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial Rap1 (Ras-Association Proximate 1) Restricts Inflammatory Signaling to Protect From the Progression of Atherosclerosis.
    Singh B; Kosuru R; Lakshmikanthan S; Sorci-Thomas MG; Zhang DX; Sparapani R; Vasquez-Vivar J; Chrzanowska M
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):638-650. PubMed ID: 33267664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corosolic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice by regulating the nuclear factor-κB signaling pathway and inhibiting monocyte chemoattractant protein-1 expression.
    Chen H; Yang J; Zhang Q; Chen LH; Wang Q
    Circ J; 2012; 76(4):995-1003. PubMed ID: 22293444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cluster of differentiation 43 deficiency in leukocytes leads to reduced atherosclerosis--brief report.
    Meiler S; Baumer Y; McCurdy S; Lee BH; Kitamoto S; Boisvert WA
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):309-11. PubMed ID: 25524774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition.
    Wilck N; Fechner M; Dreger H; Hewing B; Arias A; Meiners S; Baumann G; Stangl V; Stangl K; Ludwig A
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1418-26. PubMed ID: 22516063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.